Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
REGN
$803.48
-0.31%
REGN · Regeneron Pharmaceuticals, Inc.
$803.48
-2.49 (-0.31%)
At close · Aug 14
Market Cap
$82.72B
Shares
102.95M
All earnings calls
Earnings call · FY2026 Q2
Regeneron Pharmaceuticals, Inc. Q2 FY2026 Earnings Call
Regeneron Pharmaceuticals, Inc. Q2 FY2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$4.29B
+16.7% YoY
Diluted EPS
$12.23
-4.5% YoY
Net income
$1.30B
-6.8% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jul 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
GAAP and non-GAAP net income per diluted share
second quarter 2026
|
$-1.00 | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 30, 2026 · complete as-filed document